Back to BlackRock, Inc. BlackRock, Inc.

LENZLENZ
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in LENZ THERAPEUTICS INC

Yes. BlackRock holds 2,292,121 shares of LENZ (Lenz Therapeutics), worth $13M, as of its Q2 2026 13F filing. It increased the position by 315,298 shares (+16.0%) from Q1 2026. BlackRock has held LENZ in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$13M

Current Shares

2.3M

Total Value Change

-$9.1M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.3M
+15.9%
$13M0.0%$5.68
32
2026-Q1
Increased
2M
+16.8%
$18.1M0.0%$13.15
33
2025-Q4
Increased
1.7M
+14.9%
$27.1M0.0%$16.12
33
2025-Q3
Increased
1.5M
+2.8%
$68.6M0.0%$44.89
30
2025-Q2
Increased
1.4M
+22.8%
$42M0.0%$30.18
35
2025-Q1
Increased
1.2M
+0.9%
$30M0.0%$25.64
29
2024-Q4
Increased
1.2M
+24.3%
$33.4M0.0%$28.87
35
2024-Q3
First report
930,021
-
$22.1M0.0%$23.74
0

Other major holders of LENZ: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used